2017-03-26,How I'd Play Biotech Buyout Rumors
2017-03-24,How I'd Play Biotech Buyout Rumors
2017-03-23,Stocks Fall as House Leaders Delay Health Care Vote
2017-03-23,Noteworthy Thursday Option Activity: FLXN, Z, SWC
2017-03-23,Health Care Vote Impacts Trump's Deal Maker Image
2017-03-23,Sanofi Said to Be Near $1 Billion Deal for Flexion
2017-03-09,Flexion Reports Year-End 2016 Financial Results
2017-03-03,Flexion Therapeutics To Present At Upcoming Investor Conferences
2017-03-02,Flexion Therapeutics To Report Year-End 2016 Financial Results On March 9, 2017
2017-02-23,Flexion Therapeutics Initiates Clinical Trial To Evaluate The Safety Of Repeat Administration Of Zilretta™ (FX006) In Patients With Osteoarthritis Of The Knee
2017-02-15,Flexion Therapeutics To Present At The RBC Capital Markets Global Healthcare Conference
2017-02-07,Flexion Therapeutics Announces New Drug Application For Zilretta™ (FX006) Accepted By U.S. Food And Drug Administration
2016-12-12,Flexion Therapeutics Stock Sees Short Interest Decline 20%
2016-12-12,Flexion Therapeutics Submits New Drug Application For Zilretta™ To Treat Knee Osteoarthritis Pain
2016-12-09,Flexion Therapeutics To Present At The BMO Capital Markets Prescriptions For Success Healthcare Conference
2016-11-28,Commit To Buy Flexion Therapeutics At $10, Earn 17% Annualized Using Options
2016-11-16,Flexion Therapeutics Announces Pricing Of Public Offering Of Common Stock
2016-11-15,Flexion Therapeutics Announces Proposed Public Offering Of Common Stock
2016-11-11,Flexion Therapeutics Announces Presentation Of Phase 3 Data Demonstrating That Extended-Release Zilretta™ Achieves Clinically Significant Improvement Of Pain, Stiffness And Function In Patients With Osteoarthritis Of The Knee
2016-11-10,Insiders Seeing Green With FLXN At New 52-Week High
2016-11-07,Flexion Therapeutics Reports Third Quarter 2016 Financial Results
2016-11-03,Flexion Therapeutics Announces That Analysis From Phase 3 Clinical Trial Of Zilretta™ For Osteoarthritis Of The Knee To Be Presented At AAHKS
2016-11-01,Flexion Therapeutics Reports Primary Endpoint Met In Clinical Trial Evaluating Investigational Drug Candidate Zilretta™ In Type 2 Diabetes Patients With Knee Osteoarthritis
2016-10-28,Flexion Therapeutics To Report Third-Quarter 2016 Financial Results On November 7, 2016
2016-09-29,Flexion Therapeutics Announces Appointment Of John Magee as Vice President Of Sales
2016-09-14,Flexion Therapeutics Announces Appointment Of Mark Stejbach To Its Board Of Directors
2016-09-12,Flexion Therapeutics Announces Two Key Corporate Appointments
2016-08-31,Flexion Therapeutics To Present At 2016 Wells Fargo Healthcare Conference
2016-08-04,Seeing Some Good Action in Individual Stocks
2016-08-03,Flexion Therapeutics Reports Second-Quarter 2016 Financial Results
2016-07-25,Flexion Therapeutics To Report Second-Quarter 2016 Financial Results On August 3, 2016
2016-07-06,Flexion Therapeutics Adds Three New Executives In Key Roles To Support The Planned Commercial Launch Of Zilretta™
2016-06-08,Flexion (FLXN) Stock Plunged Today After Announcing Stock Offering
2016-06-08,Market Digging Metal and Mining Stocks
2016-06-08,Flexion Therapeutics Announces Pricing Of Public Offering Of Common Stock
2016-06-07,Flexion Therapeutics Announces Proposed Public Offering Of Common Stock
2016-05-26,Commit To Buy Flexion Therapeutics At $10, Earn 22.8% Annualized Using Options
2016-05-26,Flexion Therapeutics Receives Positive Guidance From FDA On New Drug Application (NDA) Submission For Zilretta™ For Osteoarthritis Of The Knee
2016-05-12,Flexion Therapeutics Reports First-Quarter 2016 Financial Results
2016-05-05,Flexion Therapeutics To Report First-Quarter 2016 Financial Results On May 12, 2016
2016-04-28,Flexion Therapeutics Enrolls First Patient In Phase 2 Trial Of Zilretta™ Among Type 2 Diabetes Patients With Knee Osteoarthritis
2016-04-07,Flexion Therapeutics To Present At 15th Annual Needham Healthcare Conference
2016-04-04,Flexion Therapeutics Announces Presentation Of Results From Pivotal Phase 2b And Phase 3 Clinical Trials For Zilretta™ At Osteoarthritis Research Society International (OARSI) 2016 World Congress
2016-04-01,Flexion To Present Pivotal Phase 2b And Phase 3 Results For Zilretta™ At Osteoarthritis Research Society International (OARSI) 2016 World Congress
2016-03-30,7 Stocks Under $10 to Trade for Breakout Gains
2016-03-10,Flexion Reports Year-End 2015 Financial Results
2016-03-07,Flexion Therapeutics To Present At Cowen And Company's 36th Annual Health Care Conference
2016-03-03,Flexion Therapeutics To Report Year-End 2015 Earnings Results On March 10, 2016
2016-02-29,Flexion Therapeutics Enters Oversold Territory (FLXN)
2016-02-25,Interesting FLXN Put And Call Options For April 15th
2016-02-18,Flexion Therapeutics To Present At RBC Capital Markets 2016 Global Healthcare Conference
2016-02-17,Flexion (FLXN) Stock Climbs on Phase 3 Trial Results for Osteoarthritis Treatment
2016-02-16,Flexion Therapeutics Reports Primary Endpoint Met In Pivotal Phase 3 Trial Of Zilretta™ In Knee Osteoarthritis
2016-01-20,Flexion Therapeutics Becomes Oversold (FLXN)
2015-12-04,Flexion Therapeutics To Present At Oppenheimer 26th Annual Healthcare Conference
2015-12-01,Flexion Therapeutics Enrolls First Patient In Pharmacokinetic Study Of Zilretta™ For Osteoarthritis Of The Knee
2015-11-16,Flexion Therapeutics To Present At Stifel 2015 Healthcare Conference
2015-11-09,Flexion Therapeutics Reports Third-Quarter 2015 Financial Results
2015-11-02,Flexion Therapeutics To Report Third-Quarter 2015 Financial Results On November 9, 2015
2015-09-28,First Week of May 2016 Options Trading For Flexion Therapeutics (FLXN)
2015-09-08,Tuesday's Clinical Trial Scorecard: Akebia Wins, Tetraphase, Flexion, Theravance Lose
2015-09-08,Flexion Therapeutics Reports Top-Line Data From Pivotal Phase 2b Clinical Trial For FX006
2015-09-01,Flexion Therapeutics Granted Fast Track Status By The FDA For FX006 For Treatment Of Osteoarthritis Of The Knee
2015-08-06,Flexion Therapeutics Reports Second-Quarter 2015 Financial Results
2015-08-04,Flexion Therapeutics Secures $30 Million In Debt Financing
2015-08-04,Flexion Therapeutics Expands Supply Capacity For FX006 By Entering Into Agreement With Patheon
2015-07-30,Flexion Therapeutics To Report Second-Quarter 2015 Financial Results On August 6, 2015
2015-07-29,Flexion Therapeutics Completes Enrollment In Phase 3 Clinical Trial With Lead Compound FX006 In Patients With Osteoarthritis Of The Knee
2015-07-14,Commit To Buy Flexion Therapeutics At $22.50, Earn 40.2% Annualized Using Options
2015-06-03,Flexion Therapeutics' Final FX006 Data From Completed Phase 2b Dose-Ranging Trial Published In Journal Of Bone And Joint Surgery
2015-05-07,Flexion Therapeutics Reports First-Quarter 2015 Financial Results
2015-04-30,Flexion Therapeutics To Report First-Quarter 2015 Financial Results On May 7, 2015
2015-04-29,Flexion Therapeutics Awarded Approximately $2 Million From U.S. Department Of Defense To Conduct Clinical Trial Of FX006 In Military Personnel With Osteoarthritis Of The Knee
2015-04-08,Flexion Therapeutics To Present At 14th Annual Needham Healthcare Conference
2015-03-23,Flexion Reports Year-End 2014 Financial Results
2015-03-16,Flexion Therapeutics To Report Year-End 2014 Earnings Results On March 23, 2015
2015-03-06,Flexion Therapeutics Announces Changes To Board Of Directors
2015-02-24,Flexion Therapeutics Completes Enrollment In Pivotal Phase 2b Confirmatory Clinical Trial With Lead Compound FX006
2015-02-17,Flexion Therapeutics To Present At RBC Capital Markets Healthcare Conference
2015-02-13,3 Stocks Spiking on Big Volume: Baidu, LogMeIn and Flexion
2015-02-02,Flexion Therapeutics Initiates Phase 3 Clinical Trial Of FX006 In Patients With Osteoarthritis Of The Knee
2014-12-17,Flexion Therapeutics Announces Exercise Of Underwriters' Over-Allotment Option And Closing Of Public Offering Of Common Stock
2014-12-12,Flexion Therapeutics Announces Pricing Of Public Offering Of Common Stock
2014-12-08,Flexion Therapeutics Announces Public Offering Of Common Stock
2014-12-01,Flexion Therapeutics Announces That FDA Has Removed Clinical Hold On FX006
2014-11-17,Flexion Therapeutics To Present At Stifel Healthcare Conference 2014
2014-11-13,Flexion Therapeutics Reports Third-Quarter 2014 Financial Results
2014-11-06,Flexion Therapeutics To Report Third-Quarter 2014 Financial Results
2014-09-17,Why Flexion Therapeutics (FLXN) Stock Is Plummeting in After-Hours Trading Today
2014-09-17,Flexion Therapeutics Announces Clinical Hold Of FX006 Phase 2b Clinical Trial In Osteoarthritis Of The Knee
2014-09-12,Flexion Therapeutics Keeps Climbing
2014-09-10,Fraud Allegations Cause 21Vianet Group to Plunge
2014-09-09,Flexion Therapeutics Announces Issuance Of U.S. Composition Of Matter Patent For Lead Candidate FX006
2014-09-04,Kamada Plunges Following Missed Marks in Trial
2014-09-03,Flexion Therapeutics To Start FX006 Phase 3 Pivotal Trial In 2014; Following FDA Meeting, Development Plan Advanced By One Year
2014-08-07,Flexion Therapeutics Reports Second-Quarter 2014 Financial Results
2014-07-31,Flexion Therapeutics To Report Second Quarter 2014 Financial Results On August 7, 2014
2014-07-28,Flexion Therapeutics And Southwest Research Institute(R) (SwRI(R)) Sign Worldwide Exclusive License For Proprietary Microsphere Manufacturing Technologies
2014-07-24,Flexion Therapeutics Announces Board Changes
,
,
